Results 341 to 350 of about 5,954,376 (381)
Some of the next articles are maybe not open access.
Menopause, 2013
A 65-year-old postmenopausal women comes into the office with concerns of vaginal dryness and hot flashes. She recounts numerous nights waking up drenched in sweat and days spent trying to find the coolest rooms at work. She reluctantly mentions that she and her partner have difficulty with intimacy because she has found intercourse to be painful ...
Lubna Pal +2 more
openaire +3 more sources
A 65-year-old postmenopausal women comes into the office with concerns of vaginal dryness and hot flashes. She recounts numerous nights waking up drenched in sweat and days spent trying to find the coolest rooms at work. She reluctantly mentions that she and her partner have difficulty with intimacy because she has found intercourse to be painful ...
Lubna Pal +2 more
openaire +3 more sources
Hormonal Therapy of Endometriosis
Obstetrics and Gynecology Clinics of North America, 1989Hormonal therapy has long been the mainstay of the medical management of endometriosis. However, there is considerable confusion regarding the appropriate application of hormones in the treatment of endometriosis. This article critically reviews the current status of the steroidal therapy of endometriosis.
Anthony A. Luciano, Deborah A. Metzger
openaire +3 more sources
The 2017 hormone therapy position statement of The North American Menopause Society
Menopause, 2017The 2017 Hormone Therapy Position Statement of The North American Menopause Society (NAMS) updates the 2012 Hormone Therapy Position Statement of The North American Menopause Society and identifies future research needs.
J. Pinkerton +19 more
semanticscholar +2 more sources
The Indian Journal of Pediatrics, 2005
Growth hormone (GH) therapy has revolutionized treatment of children with growth hormone deficiency (GHD). Improved height outcome with final height in the target height range has been achieved in these children. Identification of Creutzfeldt-Jakob disease, a deadly prion mediated disorder, in recipients of pituitary GH accelerated the transition from ...
P. S. N. Menon, Anurag Bajpai
openaire +3 more sources
Growth hormone (GH) therapy has revolutionized treatment of children with growth hormone deficiency (GHD). Improved height outcome with final height in the target height range has been achieved in these children. Identification of Creutzfeldt-Jakob disease, a deadly prion mediated disorder, in recipients of pituitary GH accelerated the transition from ...
P. S. N. Menon, Anurag Bajpai
openaire +3 more sources
Current Neurology and Neuroscience Reports, 2011
In 2011, there are greater than 20 antiepileptic medications available. These medications work by modulating neuronal excitability. Reproductive hormones have been found to have a role in the pathogenesis and treatment of seizures by also altering neuronal excitability, especially in women with catamenial epilepsy. The female reproductive hormones have
Cynthia L. Harden, Scott J. Stevens
openaire +3 more sources
In 2011, there are greater than 20 antiepileptic medications available. These medications work by modulating neuronal excitability. Reproductive hormones have been found to have a role in the pathogenesis and treatment of seizures by also altering neuronal excitability, especially in women with catamenial epilepsy. The female reproductive hormones have
Cynthia L. Harden, Scott J. Stevens
openaire +3 more sources
Compliance with hormone therapy
American Journal of Obstetrics and Gynecology, 1987The analysis of compliance with hormonal replacement therapy in postmenopausal women must take into account the physician's knowledge of and willingness to prescribe such treatment and the patient's acceptance of the risks and benefits. Studies have shown that most women receiving oral therapy take their medication only sporadically, and those who ...
Veronica A. Ravnikar +1 more
openaire +3 more sources
Maturitas, 1979
This study investigated the influence of hormone therapy on affect in a double blind crossover trail. The sample consisted of 49 women who had previously undergone hysterectomy and bilateral oophorectomy. Therapy consisted of 3 mth each of ethynyl oestradiol-50 micron/day, levonorgestrel-250 micron/day, "Nordial"-a combination of these two substances ...
Graeme J. Hyman +3 more
openaire +3 more sources
This study investigated the influence of hormone therapy on affect in a double blind crossover trail. The sample consisted of 49 women who had previously undergone hysterectomy and bilateral oophorectomy. Therapy consisted of 3 mth each of ethynyl oestradiol-50 micron/day, levonorgestrel-250 micron/day, "Nordial"-a combination of these two substances ...
Graeme J. Hyman +3 more
openaire +3 more sources
Clinical Obstetrics & Gynecology, 2008
Available biochemical and clinical data are sufficiently compelling to recommend low dose or transdermal hormone therapy for the management of menopausal symptoms when possible. Women initiating low dose or transdermal hormone therapy are not at increased risk of cardiovascular disease, stroke, venous thrombotic disease, and breast cancer.
openaire +3 more sources
Available biochemical and clinical data are sufficiently compelling to recommend low dose or transdermal hormone therapy for the management of menopausal symptoms when possible. Women initiating low dose or transdermal hormone therapy are not at increased risk of cardiovascular disease, stroke, venous thrombotic disease, and breast cancer.
openaire +3 more sources
Current Opinion in Chemical Biology, 1999
Hormone replacement therapy is increasingly being used for purposes unrelated to the alleviation of menopausal symptoms, such as the prevention of osteoporosis and cardiovascular disease. Clinical trials, however, suggest that the one drug/many purposes concept may be too optimistic.
Jef J. Emeis, Teake Kooistra
openaire +3 more sources
Hormone replacement therapy is increasingly being used for purposes unrelated to the alleviation of menopausal symptoms, such as the prevention of osteoporosis and cardiovascular disease. Clinical trials, however, suggest that the one drug/many purposes concept may be too optimistic.
Jef J. Emeis, Teake Kooistra
openaire +3 more sources
The 2017 hormone therapy position statement of The North American Menopause Society
Menopause, 2018The 2017 Hormone Therapy Position Statement of The North American Menopause Society (NAMS) updates the 2012 Hormone Therapy Position Statement of The North American Menopause Society and identifies future research needs.
C. Stuenkel
semanticscholar +1 more source